DiagnosisHistorical featuresSigns/symptomsRadiographic findingComments
Idiopathic Parkinson’s diseaseDifficulty with tasks, rigidity, tremorSeeTable 1No specific CT or MRI findings
Drug-induced parkinsonismPrevious use of a causative drug such as an antipsychotic, reserpine (Serpalan), or metoclopramide (Reglan)Tremor, rigidity, bradykinesia; often bilateral symptomsNormalMay persist for up to one year after discontinuation of the drug
Vascular parkinsonismStepwise progression; CVA or TIA, comorbid cardiovascular diseaseFixed deficits from previous eventsLesions in white matter with or without basal ganglia5 Common because of the prevalence of cerebrovascular disease5
Essential tremorHistory in multiple family members, little evolution5 Tremor often is action-based; absence of extrapyramidal symptoms (except possible mild rigidity); no response to levodopa5; tremor often is bilateral and can be attenuated by alcohol6 SPECT shows normal dopaminergic system5 Common5
Normal-pressure hydrocephalusAtaxia, dementia, urinary incontinenceAtaxic gait, change in mental statusCT or MRI shows hydrocephalus5 Distinctive clinical features
Progressive supranuclear palsyOnset after 40 years of age; frequent falls5 Vertical gaze paralysis (or slowed vertical saccadic movements); marked postural instability (increased fall risk within the first year of disease)5; resting tremor (rare)6; nuchal dystonia; normal olfaction7 MRI shows mesencephalon-brainstem atrophy involving the superior colliculi5
Multiple system atrophy (e.g., Shy Drager syndrome, olivopontocerebellar atrophy, nigrostriatal degeneration)Autonomic and urinary dysfunction, parkinsonism with poor levodopa response, cerebellar dysfunction5 Resting tremor (rare), transient response to levodopa (25 percent of patients)6; possible mild impaired olfaction but less severe than Parkinson’s disease8 MRI shows nigrostriatal degeneration with gliosis in the lateral putamen with hyperintense proton density bands and hypointense bands in the T2 images5 Decreased sphincter EMG results; changes in urodynamic and sympathocutaneous testing; altered cardiovascular responses5
Corticobasal degenerationCortical and cognitive impairment with involuntary movements5 Apraxia, aphasia, sensory disorders, positive Babinski test, asymmetrical parkinsonism without impaired deambulation (difficulty in stopping gait), myoclonus, dystonia5 MRI shows asymmetric atrophy of frontal and parietal regions, there may be atrophy of basal ganglia and/or corpus callosum; PET shows decreased glucose metabolism in frontoparietal cortex, thalamus, and basal gangliaCommonly Underdiagnosed because of its heterogeneity5
Dementia with Lewy bodiesCognitive impairment, hallucinations, episodes of delirium, parkinsonism5 Impaired attention and visuospatial abilities, increased falls, episodes of syncope5 PET shows low glucose metabolism in cortex5 Marked intolerance to neuroleptic drugs5